Pfizer Inc. is doubling down on the booming weight-loss drug race, with CEO Albert Bourla declaring the company will be a "formidable competitor" after securing a $10 billion deal to acquire ...
Pfizer (PFE) CEO and chairman Albert Bourla told Yahoo Finance Executive Editor Brian Sozzi during Yahoo Finance's annual Investconference that the $10 billion acquisition of GLP-1 maker Metsera (MTSR ...
Hosted on MSN
Pfizer raises full-year 2025 EPS guidance to $3–$3.15 amid Metsera acquisition progress and R&D pipeline expansion
CEO Albert Bourla highlighted that "the past few months have been pivotal for Pfizer" with key developments including an agreement with the U.S. government, the proposed acquisition of Metsera, and ...
The drugmaker reported revenue that fell from a year ago amid slumping sales of COVID vaccines and treatments, but still topped expectations Pfizer's buyout bid for Metsera was deemed inferior to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results